Other

Other receivables

Elevance Health Other receivables decreased by 2.2% to $6.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.2%, from $6.58B to $6.17B. Over 5 years (FY 2020 to FY 2025), Other receivables shows an upward trend with a 17.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ4 2024
Last reportedQ4 2025

How to read this metric

Significant fluctuations may indicate one-time events or changes in operational accounting practices rather than core business performance.

Detailed definition

Captures miscellaneous claims or amounts due to the firm that do not fall under standard trade receivables or management...

Peer comparison

Varies widely by firm; typically a small fraction of total assets.

Metric ID: other_other_receivables

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.25B$3.45B$3.75B$3.33B$3.60B$3.65B$4.30B$4.68B$5.20B$5.29B$5.41B$5.12B$5.88B$6.06B$6.02B$6.58B$7.21B$7.69B$6.31B$6.17B
QoQ Change+6.3%+8.7%-11.1%+8.0%+1.4%+17.7%+8.8%+11.1%+1.9%+2.1%-5.3%+14.9%+3.0%-0.6%+9.3%+9.6%+6.7%-18.0%-2.2%
YoY Change+10.9%+5.8%+14.6%+40.3%+44.3%+45.0%+25.8%+9.4%+13.2%+14.4%+11.3%+28.4%+22.5%+27.0%+4.8%-6.2%
Range$3.25B$7.69B
CAGR+14.5%
Avg YoY Growth+19.5%
Median YoY Growth+14.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is Elevance Health's other receivables?
Elevance Health (ELV) reported other receivables of $6.17B in Q1 2026.
How has Elevance Health's other receivables changed year-over-year?
Elevance Health's other receivables decreased by 6.2% year-over-year, from $6.58B to $6.17B.
What is the long-term trend for Elevance Health's other receivables?
Over 5 years (2020 to 2025), Elevance Health's other receivables has grown at a 17.4% compound annual growth rate (CAGR), from $2.83B to $6.31B.
What does other receivables mean?
Miscellaneous short-term amounts owed to the company from various non-core business activities.